Jacobs Levy Equity Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Buy |
+820,504
| New | +$1.7M | 0.01% | 655 |
|
|
2021
Q3 | – | Sell |
-295,276
| Closed | -$4.58M | – | 1075 |
|
|
2021
Q2 | $4.58M | Sell |
295,276
-347,199
| -54% | -$5.39M | 0.03% | 447 |
|
|
2021
Q1 | $10.4M | Buy |
642,475
+616,717
| +2,394% | +$10M | 0.08% | 289 |
|
|
2020
Q4 | $545K | Buy |
+25,758
| New | +$545K | ﹤0.01% | 840 |
|
|
2020
Q2 | – | Sell |
-29,938
| Closed | -$351K | – | 1089 |
|
|
2020
Q1 | $351K | Buy |
+29,938
| New | +$351K | ﹤0.01% | 807 |
|
|
2016
Q3 | – | Sell |
-10,560
| Closed | -$191K | – | 1065 |
|
|
2016
Q2 | $191K | Sell |
10,560
-28,100
| -73% | -$508K | ﹤0.01% | 1015 |
|
|
2016
Q1 | $734K | Buy |
+38,660
| New | +$734K | 0.02% | 639 |
|